Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPressure Tech Regulatory News (PRES)

  • There is currently no data for PRES

Director's Interest

15 Oct 2010 16:32

RNS Number : 5056U
Pressure Technologies PLC
15 October 2010
 



 

Pressure Technologies PLC

 

("Pressure Technologies" or the "Company")

 

Director's Interest

 

Pressure Technologies was informed on 8 October 2010 by Brewin Dolphin Limited ("BDL") that as of 7 October 2010 it held an indirect interest in 119,005 ordinary shares of the Company representing 1.05% of the issued ordinary share capital and voting rights of the Company. The indirect interests are in 49,984 ordinary shares held by Brewin Nominees Limited and 69,021 ordinary shares held by Giltspur Nominees Limited. Prior to the notification above, BDL had an interest in 1,130,471 ordinary shares of Pressure Technologies, representing 9.97% of the issued ordinary share capital and voting rights of the Company.

 

Of the previous interest of BDL referred to above, 1,000,040 ordinary shares, representing 8.82% of the issued ordinary share capital and voting rights of the Company, were held and continue to be held on behalf of John Hayward, the Chief Executive Officer of Pressure Technologies. The change of BDL's interest has arisen because certain shareholdings (including John Hayward's shareholding) are now held on an advisory basis rather than a discretionary basis by BDL. For the sake of clarity, John Hayward's beneficial interest in the share capital of the Company, being 1,000,040 ordinary shares representing 8.82% of the issued share capital of the Company, remains unchanged by this event.

 

 

For further information, please contact:

 

Pressure Technologies plc

John Hayward, Chief Executive

James Lister, Group Finance Director

 

Tel: 0114 242 7500

www.pressuretechnologies.co.uk

 

Fairfax IS PLC

Ewan Leggat/Simon Bennett

 

Tel: 0207 598 5368 

Rawlings Financial PR Limited

Catriona Valentine

 

Tel: 01653 618 016

www.rawlingsfinancial.co.uk

 

 

Company description:

 

Pressure Technologies is the holding company for Chesterfield Special Cylinders Limited ("CSC"). CSC designs, manufactures and offers retesting and refurbishment services for a range of speciality high-pressure, seamless steel gas cylinders for global energy and defence markets. The business has been conducted under the "Chesterfield" brand which is a long established name in the cylinders and specialised pressure vessel market.

 

Chesterfield BioGas ("CBG"), an operating division of Pressure Technologies, formed in November 2008 following the signing of a co-operation agreement with Greenlane Biogas Limited, the world leader in biogas upgrading from raw biogas to vehicle quality fuel, gives Pressure Technologies exclusive rights to market Greenlane equipment in the UK and Eire. Chesterfield BioGas will provide turnkey solutions for the cleaning, storage and dispensing of biomethane, produced from waste water treatment and anaerobic digestion of organic waste.

 

Al-Met Limited ("Al-Met"), which was acquired by the Group in February 2010, is a niche manufacturer of specialised, precision engineered valve wear parts used in the oil and gas industries, based in Pontyclun, near Cardiff. Al-Met's products are used in high-pressure choke and flow control valves, designed to regulate flow volumes in extremely demanding applications in the subsea and surface oil and gas industries. The business, established in 1985, has developed a leading edge capability in precision machining carbides and superalloy matrix materials. The ability to combine high alloy steels with tungsten carbide inserts and specialised coatings gives Al-Met its niche position with its customers, global wellhead and subsea equipment OEMs.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEASESFDAEFFF
Date   Source Headline
27th May 20159:40 amRNSHolding(s) in Company
8th Apr 20153:25 pmRNSHolding(s) in Company
7th Apr 201511:13 amRNSHolding(s) in Company
2nd Apr 20153:47 pmRNSHolding(s) in Company
6th Mar 20153:48 pmRNSHolding(s) in Company
12th Feb 20154:20 pmRNSResult of AGM
5th Feb 20157:00 amRNSUpdate on Trading and Prospects
30th Jan 20153:14 pmRNSTotal Voting Rights
22nd Jan 20159:00 amRNSHolding(s) in Company
19th Jan 20157:00 amRNSProperty Acquisition
23rd Dec 20143:50 pmRNSIssue of Equity
19th Dec 20143:46 pmRNSPublication of Annual Accounts
19th Dec 20143:39 pmRNSHolding(s) in Company
15th Dec 20147:30 amRNSGrant of Share Options
9th Dec 20147:00 amRNSFinal Results
28th Nov 20147:00 amRNSTotal Voting Rights
27th Nov 201411:21 amRNSChange of Registered Office
27th Nov 20147:00 amRNSNotice of Preliminary Results
30th Oct 20147:00 amRNSIssue of Equity
20th Oct 20143:18 pmRNSHolding(s) in Company
17th Oct 20141:33 pmRNSIssue of Equity
1st Oct 20147:01 amRNSAcquisition of Quadscot Holdings Limited
1st Oct 20147:00 amRNSNew Bank Facilities
18th Sep 20147:00 amRNSAcquisition
1st Sep 201411:45 amRNSIssue of Equity
1st Aug 201411:25 amRNSGrant of Share Options
31st Jul 20148:00 amRNSTotal Voting Rights
21st Jul 20145:03 pmRNSDirector/PDMR Shareholding
11th Jul 201412:43 pmRNSAcquisition of shares by a Director
10th Jun 20147:00 amRNSHalf Yearly Report
30th May 20147:00 amRNSTotal Voting Rights
27th May 20147:00 amRNSNotice of Results
19th May 20147:00 amRNSIssue of Equity
4th Apr 20147:00 amRNSGrant of Share Options
31st Mar 20149:00 amRNSTotal Voting Rights
28th Mar 20149:47 amRNSHolding(s) in Company
12th Mar 20147:00 amRNSHolding(s) in Company
7th Mar 20141:10 pmRNSHolding(s) in Company
7th Mar 201412:04 pmRNSHolding(s) in Company
5th Mar 20147:00 amRNSAcquisition & Placing
13th Feb 20141:10 pmRNSResult of AGM
13th Feb 20147:00 amRNSAGM Statement
21st Jan 20147:00 amRNSContract win for Chesterfield BioGas
23rd Dec 20138:00 amRNSAnnual Financial Report
13th Dec 20137:00 amRNSStrategic Investment
3rd Dec 20137:00 amRNSPreliminary Results 2013
20th Nov 20138:00 amRNSAnalyst Briefing
23rd Oct 20137:00 amRNSNotice of Results and Trading Update
21st Aug 20137:00 amRNSContract wins for Chesterfield BioGas
20th Aug 201312:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.